The pharmaceutical company said late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in the risk of the disease progressing or death.

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...

Two Scottish health boards are trialing a revolutionary artificial intelligence scanning of X-rays to detect signs of lung ...

Smoking affects many parts of the body, especially the lungs and heart. Regular health checkups can help catch problems early ...

The purpose of this article is to present the historic and current trends of tobacco use as relates to lung cancer, discuss the effects of tobacco on outcomes in patients with lung cancer, discuss the ...

qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA ... patients with previous or current evidence of interstitial lung disease (ILD) were excluded. An Eastern ...

Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced the official launch ...

New robotic technology has arrived at Puyallup’s MultiCare Good Samaritan Hospital – and it creates a world of difference for ...

I sat beside my dad's bed a few days before he passed away and I made him a promise - that I will continue to tell his story ...